trametinib

GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Sat, 07/19/14 - 09:20 am
trametinib
GSK
vemurafenib
dabrafenib
melanoma
Pfizer, Glaxo to initiate study of combination therapy in patients with melanoma
The Fly on the Wall
Thu, 11/21/13 - 08:25 am
GSK
Pfizer
melanoma
trametinib
palbociclib
Glaxo's Melanoma Drugs Gets FDA Priority Review
PharmaLive
Mon, 09/16/13 - 05:49 pm
melanoma
GSK
FDA
Tafinlar
Mekinist
trametinib
dabrafenib
metastatic melanoma
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Fierce Biotech
Wed, 05/29/13 - 04:49 pm
FDA
GSK
melanoma
dabrafenib
trametinib
GlaxoSmithKline Begins Phase 3 Melanoma Study
Motley Fool
Mon, 02/4/13 - 11:24 am
GSK
melanoma
BRAF inhibitor
dabrafenid
MEK inhibitor
trametinib
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Sat, 09/29/12 - 11:55 am
GSK
melanoma
dabrafenib
trametinib
Glaxo Files Two Melanoma Drugs For U.S., Europe Approvals
Bloomberg
Fri, 08/3/12 - 11:23 am
melanoma
GSK
trametinib
dabrafenib
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Bloomberg
Mon, 06/4/12 - 06:02 pm
GSK
melanoma
dabrafenib
trametinib